Skip to main content
. Author manuscript; available in PMC: 2023 May 8.
Published in final edited form as: J Med Chem. 2013 Mar 15;56(6):2246–2255. doi: 10.1021/jm301280p

Figure 3.

Figure 3.

Conventional peptide hydroxamates show varying degrees of selectivity for IDE. Dose-response curves for inhibitors 1a (A), 8a (B), 8b (C) and 14a (D) against IDE, NEP, ECE1, ACE, MMP2 and MMP7. The legend in panel B (inset) applies to all graphs. Note that MMP7 is rather potently inhibited by inhibitors 1a and 8a, but not by inhibitors 8b or 14a.